P.r. Herzig buys $429,091 stake in MEDNAX Inc (MD)

MEDNAX Inc (MD) : P.r. Herzig scooped up 3,250 additional shares in MEDNAX Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 14, 2016. The investment management firm now holds a total of 6,550 shares of MEDNAX Inc which is valued at $429,091.MEDNAX Inc makes up approximately 0.86% of P.r. Herzig’s portfolio.

Other Hedge Funds, Including , Fjarde Ap-fonden Fourth Swedish National Pension Fund reduced its stake in MD by selling 462 shares or 1.64% in the most recent quarter. The Hedge Fund company now holds 27,763 shares of MD which is valued at $1,818,754. MEDNAX Inc makes up approx 0.04% of Fjarde Ap-fonden Fourth Swedish National Pension Fund’s portfolio.Eagle Asset Management Inc boosted its stake in MD in the latest quarter, The investment management firm added 4,660 additional shares and now holds a total of 744,674 shares of MEDNAX Inc which is valued at $48,895,295. MEDNAX Inc makes up approx 0.34% of Eagle Asset Management Inc’s portfolio.British Columbia Investment Management Corp boosted its stake in MD in the latest quarter, The investment management firm added 6,203 additional shares and now holds a total of 73,249 shares of MEDNAX Inc which is valued at $4,809,529. MEDNAX Inc makes up approx 0.05% of British Columbia Investment Management Corp’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in MD by selling 32,147 shares or 81.84% in the most recent quarter. The Hedge Fund company now holds 7,132 shares of MD which is valued at $477,273. Eqis Capital Management added MD to its portfolio by purchasing 4,472 company shares during the most recent quarter which is valued at $299,266. MEDNAX Inc makes up approx 0.02% of Eqis Capital Management’s portfolio.

MEDNAX Inc closed down -0.65 points or -0.98% at $65.51 with 4,82,563 shares getting traded on Friday. Post opening the session at $66.46, the shares hit an intraday low of $65.26 and an intraday high of $66.79 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, MEDNAX Inc reported $1.03 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus of $1.07. The company had revenue of $771.80 million for the quarter, compared to analysts expectations of $774.46 million. The company’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 EPS.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.